[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity

Rhea-AI Filing Summary

USANA Health Sciences chief commercial officer Brent Neidig reported two open-market sales of common stock. On June 12, he sold 1,602 shares at $20.15 per share. On June 15, he sold an additional 909 shares at $20.005 per share. After these transactions, he directly holds 5,002 shares of USANA common stock.

Insights

Equity analyst

USANA CCO made modest open-market share sales while retaining a direct equity stake.

Chief commercial officer Brent Neidig executed two open-market sales totaling 2,511 shares of USANA common stock at prices just above $20 per share. These are straightforward non-derivative transactions with no options exercises or complex instruments reported.

Following the sales, Neidig continues to hold 5,002 shares directly, indicating he maintains meaningful exposure to the company’s stock. The filing shows no derivative positions and no references to trading plans or tax-driven dispositions, suggesting routine personal portfolio management rather than a structural change for the company.

Insider Trade Summary

Net Seller: 2,511 shares ($50,465)

Net Sell 2 txns

Insider Neidig Brent

Role CHIEF COMMERCIAL OFFICER

Sold 2,511 shs ($50K)

Type	Security	Shares	Price	Value
Sale	Common Stock	909	$20.005	$18K
Sale	Common Stock	1,602	$20.15	$32K

Holdings After Transaction: Common Stock — 5,002 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold 12 June: 1,602 shares Price 12 June sale: $20.15/share Shares sold 15 June: 909 shares +3 more

6 metrics

Shares sold 12 June 1,602 shares Open-market sale of common stock at $20.15 per share

Price 12 June sale $20.15/share Open-market sale of 1,602 common shares

Shares sold 15 June 909 shares Open-market sale of common stock at $20.005 per share

Price 15 June sale $20.005/share Open-market sale of 909 common shares

Total shares sold 2,511 shares Combined open-market sales reported in this Form 4

Shares held after transactions 5,002 shares Direct ownership of USANA common stock following sales

Key Terms

open-market sale, Common Stock, non-derivative, direct ownership

4 terms

open-market sale financial

"transaction_action: "open-market sale" for each common stock transaction"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock" for both reported transactions"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"transaction_type: "non-derivative" indicating regular share trades"

direct ownership financial

"ownership_type: "direct" and ownership_code: "D" for both entries"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/16/2026 - 03:42 PM Accepted by SEC EDGAR 06/16/2026 - 03:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Neidig Brent

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UTAH 84120

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF COMMERCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/12/2026		S		1,602	D	$20.15	5,911	D
Common Stock	06/15/2026		S		909	D	$20.005	5,002	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)